S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
S&P 500   3,331.64 (-0.60%)
DOW   27,383.96 (-0.73%)
QQQ   276.30 (-0.32%)
AAPL   114.04 (-0.80%)
MSFT   208.34 (-0.53%)
FB   258.88 (+0.80%)
GOOGL   1,458.31 (-0.02%)
AMZN   3,165.82 (-0.26%)
TSLA   426.36 (+1.23%)
NVDA   526.98 (+1.07%)
BABA   277.69 (+0.61%)
CGC   14.60 (+2.74%)
MU   50.67 (+1.91%)
GE   6.07 (-2.10%)
AMD   81.42 (+2.44%)
T   28.17 (-0.74%)
F   6.57 (-1.79%)
ACB   4.97 (+3.97%)
GILD   62.16 (-1.10%)
NFLX   490.58 (-0.01%)
DIS   124.00 (-1.58%)
BA   162.84 (-1.95%)
BAC   23.61 (-1.99%)
Log in
OTCMKTS:INIS

International Isotopes Stock Forecast, Price & News

$0.06
0.00 (0.00 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.06
Now: $0.06
$0.06
50-Day Range
$0.05
MA: $0.06
$0.06
52-Week Range
$0.04
Now: $0.06
$0.07
Volume20,000 shs
Average Volume60,761 shs
Market Capitalization$24.61 million
P/E RatioN/A
Dividend YieldN/A
Beta0.16
International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt teletherapy sources, and radioisotopes and radiochemicals for medical research, pharmacy compounding, and clinical applications. The company operates in six segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot markers, pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy or various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals for medical, industrial, and research applications. It provides iodine-131 radiochemical for use in the treatment and diagnosis of diseases of the thyroid gland, such as graves' disease, thyroid cancer, and hyperthyroidism, as well as for breast, lung, prostate, and ovarian cancers. The Fluorine Products segment offers products that are used to support the production and sale of gases produced using its fluorine extraction process. The Radiological Services segment decommissions disused irradiation units, performs sealed source exchanges in irradiation and therapy units, and processes gemstones. The Transportation segment provides transportation services for hazardous and non-hazardous cargo materials. The company sells its products directly to end users and distributors. International Isotopes, Inc. was founded in 1995 and is headquartered in Idaho Falls, Idaho.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryN/A
Current SymbolOTCMKTS:INIS
CUSIPN/A
Phone208-524-5300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.95 million

Profitability

Net Income$-1,520,000.00

Miscellaneous

Employees30
Market Cap$24.61 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$0.06
0.00 (0.00 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INIS News and Ratings via Email

Sign-up to receive the latest news and ratings for INIS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











International Isotopes (OTCMKTS:INIS) Frequently Asked Questions

How has International Isotopes' stock been impacted by Coronavirus (COVID-19)?

International Isotopes' stock was trading at $0.0580 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INIS stock has increased by 0.0% and is now trading at $0.0580.
View which stocks have been most impacted by COVID-19
.

When is International Isotopes' next earnings date?

International Isotopes is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for International Isotopes
.

How were International Isotopes' earnings last quarter?

International Isotopes Inc. (OTCMKTS:INIS) posted its quarterly earnings results on Monday, April, 2nd. The technology company reported $0.00 earnings per share (EPS) for the quarter. The technology company had revenue of $1.90 million for the quarter. International Isotopes had a negative return on equity of 1,760.72% and a negative net margin of 5.77%.
View International Isotopes' earnings history
.

Are investors shorting International Isotopes?

International Isotopes saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 3,700 shares, an increase of 48.0% from the July 30th total of 2,500 shares. Based on an average trading volume of 82,400 shares, the short-interest ratio is currently 0.0 days.
View International Isotopes' Short Interest
.

Who are some of International Isotopes' key competitors?

What other stocks do shareholders of International Isotopes own?

Who are International Isotopes' key executives?

International Isotopes' management team includes the following people:
  • Mr. Stephen T. Laflin, Pres, CEO & Director (Age 62)
  • Ms. Laurie A. McKenzie-Carter, CFO & Sec. (Age 62)

What is International Isotopes' stock symbol?

International Isotopes trades on the OTCMKTS under the ticker symbol "INIS."

How do I buy shares of International Isotopes?

Shares of INIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is International Isotopes' stock price today?

One share of INIS stock can currently be purchased for approximately $0.06.

How big of a company is International Isotopes?

International Isotopes has a market capitalization of $24.61 million and generates $8.95 million in revenue each year. International Isotopes employs 30 workers across the globe.

What is International Isotopes' official website?

The official website for International Isotopes is www.intisoid.com.

How can I contact International Isotopes?

International Isotopes' mailing address is 4137 COMMERCE CIRCLE, IDAHO FALLS ID, 83401. The technology company can be reached via phone at 208-524-5300 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.